Autovaccination plus heat-inactivated autologous plasma in AIDS patients

Acquired factor VIII inhibitors in nonhemophilic patients.

Annals of hematology·1997

[Transfusion medicine in unified Europe. Brief report on the status of transfusion medicine in central and east European countries].

Infusionstherapie und Transfusionsmedizin·1994

[Ex-vivo bleeding time as a control for platelet transfusion].

Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine·1994

[Resuscitation necessitated by a transfusion reaction after HLA mismatched platelets substitution].

Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine·1994

[T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].

Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine·1994

[Plasminogen activator inhibitor 1--a new thrombosis risk marker].

Deutsche medizinische Wochenschrift (1946)·1992

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Lancet (London, England)·2026

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

Lancet (London, England)·2026

Global research trends in fecal microbiota transplantation combined with immune checkpoint inhibitors for cancer immunotherapy: a bibliometric analysis.

Translational cancer research·2026

Development and clinical implementation of a local automated kidney allocation platform integrating virtual crossmatch.

Frontiers in immunology·2026

Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering.

Immunological investigations·2026

[Perioperative Breast Cancer Treatment with Immune Checkpoint Inhibitors-Current Status and Future Perspectives].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Incidence and Predictors of Immune-Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real-World Cohort Study.

International journal of cancer·2026

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Bone marrow transplantation·2026

Related Experiment Videos

Autovaccination plus heat-inactivated autologous plasma in AIDS patients

Related Concept Videos

Acquired factor VIII inhibitors in nonhemophilic patients.

[Transfusion medicine in unified Europe. Brief report on the status of transfusion medicine in central and east European countries].

[Ex-vivo bleeding time as a control for platelet transfusion].

[Resuscitation necessitated by a transfusion reaction after HLA mismatched platelets substitution].

[T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].

[Plasminogen activator inhibitor 1--a new thrombosis risk marker].

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Use of the bacterial lysate OM-85 for the primary prevention of wheezing lower respiratory illness in preschool children: a randomised, placebo-controlled trial.

Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030.

Global research trends in fecal microbiota transplantation combined with immune checkpoint inhibitors for cancer immunotherapy: a bibliometric analysis.

Development and clinical implementation of a local automated kidney allocation platform integrating virtual crossmatch.

Immunometabolic Reprogramming as a Therapeutic Platform: Integrating Systems Immunology with Precision Biopharmaceutical Engineering.

[Perioperative Breast Cancer Treatment with Immune Checkpoint Inhibitors-Current Status and Future Perspectives].

Incidence and Predictors of Immune-Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real-World Cohort Study.

Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party.

Related Experiment Videos

Autovaccination plus heat-inactivated autologous plasma in AIDS patients

Related Concept Videos

Related Articles